Ratings by Rothschild Redburn (Ed Ridley-Day)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 10/2/2026 | Abbott Labs | ABT | Upgrade | Buy (Neutral) |
98.83 (102.86) |
4.08% | Details | |
| 1/12/2026 | Medline Inc | MDLN | New Coverage | Neutral (N/A) |
41.25 (35.32) |
-14.38% | Details | |
| 10/8/2025 | Danaher | DHR | Downgrade | Neutral (Buy) |
211.71 (226.11) |
6.8% | Details | |
| 9/18/2025 | Zimmer Biomet | ZBH | New Coverage | Buy (N/A) |
99.12 (95.39) |
-3.76% | Details | |
| 9/18/2025 | Stryker | SYK | New Coverage | Neutral (N/A) |
376.62 (303.38) |
-19.45% | Details | |
| 9/3/2024 | Lantheus Holdings | LNTH | New Coverage | Buy (N/A) |
104.81 (100.08) |
-4.51% | Details | |
| 8/2/2024 | Intuitive Surgical | ISRG | Upgrade | Buy (Neutral) |
444.61 (436.57) |
-1.81% | Details |
